Concepedia

Publication | Open Access

<scp>COVID</scp> ‐19 Vaccine Response in People with Multiple Sclerosis

150

Citations

33

References

2021

Year

Abstract

Some disease modifying therapies convey risk of attenuated serological response to SARS-CoV-2 vaccination in people with MS. We provide recommendations for the practical management of this patient group. ANN NEUROL 20219999:n/a-n/a.

References

YearCitations

Page 1